期刊名称：CARDIORENAL MEDICINE ISSN： 1664-3828 出版频率： Quarterly 出版社： KARGER, ALLSCHWILERSTRASSE 10, BASEL, SWITZERLAND, CH-4009   出版社网址： http://www.karger.com/ 期刊网址： www.karger.com/CRM 影响因子： 2.041 主题范畴： CARDIAC & CARDIOVASCULAR SYSTEMS;    UROLOGY & NEPHROLOGY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Cardiorenal Medicine Journal Abbreviation: Cardiorenal Med ISSN: 1664-3828 (Print) e-ISSN: 1664-5502 (Online) www.karger.com/CRM Metabolic abnormalities, heart and kidney disease Aims and Scope The journal of 'CardioRenal Medicine' explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues. Attention is paid to the fact that some metabolic abnormalities cluster with heart and chronic kidney disease, and collectively this is called the cardiorenal metabolic syndrome. Moreover, certain metabolic abnormalities of the heart promote impaired coronary artery endothelial function, diastolic dysfunction and ischemic reconditioning that parallel glomerular hyperfiltration and impairments in proximal tubule handling of sodium and albumin. Another point of focus is the role of the obesity epidemic in promoting the increasing incidence of heart and kidney disease in industrialized countries and the prevailing problems of insufficient exercise and excessive consumption of cheap, unwholesome food in promotion of the cardiorenal metabolic syndrome in both adults and children. Indexing/Abstracting Listed in bibliographic services, including Current Contents/Clinical Medicine, Journal Citation Reports/Science Edition, Science Citation Index Expanded   Instructions to Authors Guidelines for Authors www.karger.com/crm_guidelines Submission Conditions Types of Articles Conflict of Interest Ethics Plagiarism Policy Arrangement Color Illustrations References Digital Object Identifier (DOI) Supplementary Material NIH-Funded Research, Self-Archiving Page charges Proofs Reprints Submission 'CardioRenal Medicine' only accepts online submissions: Online Manuscript Submission All further technical instructions can be found there. Conditions The journal will not publish articles which have been previously reported at any length or articles being considered for publication elsewhere. The authors must include a statement to this effect in their cover letter. If publication of the data in any form has occurred or is being contemplated, a copy of such publication should be included with the submitted manuscript. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications. The manuscript should be written in English and the editors reserve the right to make appropriate corrections in grammar and style. Accepted papers become the permanent property of 'CardioRenal Medicine' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. Information concerning financial disclosures (i.e. grants, funding, support, etc.) should be placed at the foot of the title page. Types of Articles for Acceptance 1. Original Papers: Representing full sets of completed experiments in the areas of either clinical or basic research that answer a given question. Max. 3,000 words, incl. figures, tables. Maximum 25 references. 2. Reviews: Covering a timely topic by experts in the field. An Abstract is required and should be divided into Background, Summary and Key Messages. Max. 4,500 words, incl. figures, tables. Maximum 60 references. Conflict of Interest Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article. Ethics Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards. Plagiarism Policy Plagiarism PolicyWhether intentional or not, plagiarism is a serious violation. We define a case of plagiarism if there is 25% similarity in the Results or Discussion that exactly reproduces another paper without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s). Arrangement Title page: The first page of each paper should indicate the title, the authors' names, the institute where the work was conducted, a short title for use as running head, conflict of interest statement, and word count. Manuscripts are to be double-spaced and formatted using the same font, size 12 throughout text and references. Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address. Key words: Please supply 3–10 key words in English that reflect the content of the paper. Abstract of Original Papers: Each paper needs an abstract of up to 250 words. Except for reviews, abstracts should be structured as follows:    Background/Aims: What is the major problem that prompted the study?    Methods: How was the study performed?    Results: Most important findings?    Conclusion: Most important conclusion? Abstract of Reviews: Should be divided into the following subsections: Background, Summary and Key Messages. The Background should provide a brief clinical context for the review and is followed by the Summary, which should include a concise description of the main topics covered in the text. The Key Messages encapsulate the main conclusions of the review. Footnotes: Avoid footnotes. Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi. Average table = 250 words. The maximum size of all uploaded files is 40 Mb. Color Illustrations Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 800.– per page. References In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, cite all authors. Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Examples (a) Papers published in periodicals: Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:14–18. (b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858. (c) Monographs: Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 4, revised. Basel, Karger, 2007. (d) Edited books: DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137. Reference Management Software: Use of EndNote® is recommended for easy management and formatting of citations and reference lists. Digital Object Identifier (DOI) S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org. Supplementary Material Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the data cannot be converted properly to a PDF file), and video files (.mov, .avi, .mpeg). NIH-Funded Research The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits your manuscript on your behalf to PubMed Central (PMC) immediately upon publication. It usually receives a PMCID within approximately a month and will appear in PMC after 12 months. For those selecting our premium Author's ChoiceTM service, the usual embargo will be overridden, accelerating the accessibility of your work. More details on NIH's Public Access Policy are available here. Self-Archiving Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's Author's ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links. Page charges There are no page charges for papers of 5 printed pages. Each additional complete or partial page will be charged to the author at the rate of CHF 325.00 per page. Proofs Unless indicated otherwise, proofs are sent to the first-named author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author. Reprints Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices. Editorial Board Editorial Board www.karger.com/crm_editors Editor J.R. Sowers, Columbia, Mo. Assistant Editor B. Hunter, Columbia, Mo. Associate Editors S. Brietzke, Columbia, Mo. M. Bursztyn, Jerusalem K.C. Dellsperger, Columbia, Mo. V. DeMarco, Columbia, Mo. J.P. Dwyer, Nashville, Tenn. K.C. Ferdinand, New Orleans, La. J.M. Flack, Detroit, Mich. E.P. Gomez-Sanchez, Jackson, Miss. M.R. Hayden, Camdenton, Mo. E.J. Henriksen, Tucson, Ariz. J.M. Luther, Nashville, Tenn. F. Murad, Washington, D.C. C. Ronco, Vicenza N. Stern, Tel Aviv C.S. Stump, Tucson, Ariz. A.T. Whaley-Connell, Columbia, Mo. Editorial Board M.A. Alpert, Columbia, Mo. G.L. Bakris, Chicago, Ill. M. Barbagallo, Palermo S.B. Bender, Columbia, Mo. T. Berl, Aurora, Colo. S.L. Britton, Ann Arbor, Mich. N.J. Brown, Nashville, Tenn. V.M. Campese, Los Angeles, Calif. A.R. Chacra, Sao Paulo K. Chaudhary, Columbia, Mo. M. Cooper, Melbourne, Vic. C.F. Deacon, Copenhagen P. Deedwania, Fresno, Calif. L. Dominguez, Palermo M. Epstein, Miami, Fla. E. Fabbrini, St. Louis, Mo. B. Falkner, Philadelphia, Pa. E.D. Frohlich, New Orleans, La. T. Fujita, Tokyo J. Funder, Wandin East, Vic. W.T. Garvey, Birmingham, Ala. F. Giorgino, Bari D. Goldsmith, London C.E. Gomez-Sanchez, Jackson, Miss. J.E. Hall, Jackson, Miss. J.M. Hershman, Los Angeles, Calif. M. Husain, Toronto, Ont. S. Ito, Sendai F. Jaisser, Paris A. Jindal, Columbia, Mo. K. Kalantar-Zadeh, Orange, Calif. C.T. Kappagoda, Davis, Calif. S. Klein, St. Louis, Mo. T. Klein, Biberach Y. Kokubo, Osaka D.T. Lackland, Charleston, S.C. G. Lastra, Columbia, Mo. P.S. Leung, Hong Kong M. Levi, Aurora, Colo. W. Lockette, Arlington, Va. D.B. Lombard, Ann Arbor, Mich. C. Manrique, Columbia, Mo. L.A. Martinez-Lemus, Columbia, Mo. R.W. McCallum, El Paso, Tex. S.I. McFarlane, Brooklyn, N.Y. B. Mitchell, Temple, Tex. R. Muniyappa, Bethesda, Md. P.M. Nilsson, Malmö R. Nistala, Columbia, Mo. D.K. Pandey, Chicago, Ill. L. Peterson, St. Louis, Mo. S. Petrides, Scottsdale, Ariz. R.A. Phillips, Houston, Tex. D. Porte, Jr., La Jolla, Calif. W. Rainey, Ann Arbor, Mich. M.K. Raizada, Gainesville, Fla. A. Rathod, Los Angeles, Calif. R.S. Rector, Columbia, Mo. J. Ren, Laramie, Wyo. T. Rosenthal, Tel Aviv L.M. Ruilope, Madrid W.K. Samson, St. Louis, Mo. R.W. Schrier, Aurora, Colo. K.R. Short, Oklahoma City, Okla. B. Sing, Paradise Valley, Ariz. K. Sowers, Las Vegas, Nev. H. Szerlip, Tucson, Ariz. B. Terry, Columbia, Mo. J. Thyfault, Columbia, Mo. R.M. Touyz, Glasgow E.M. Urbina, Cincinnati, Ohio J. Varagic, Winston-Salem, N.C. J.A. Vassalotti, New York, N.Y. M. Velasco, Los Teques K. Vijay, Scottsdale, Ariz. D. Villarreal, Syracuse, N.Y. R.C. Webb, Augusta, Ga. R. Zimlichman, Tel Aviv R.P. Zitsch III, Columbia, Mo. M.-H. Zou, Oklahoma City, Okla.